Is Artificial Intelligence Revolutionising Pharmaceutical Analytics in Europe?

• Innoplexus is a german startup which aims to streamline the process of data analytics in the pharmaceutical and life science industry through advanced technologies such as Artificial Intelligence, Blockchain and advanced analytics.
• They work towards a continuous decision-making process in enterprises to make them more efficient and cost-effective.
• Innoplexus provides Data as a Service (DaaS) and Continuous Analytics as a Service (CaaS) to Fortune 500 companies.
• The startup also focuses on advancing medical research and facilitating healthcare organizations to expedite the drug development process.

Embedded in the heart of Europe, a startup named Innoplexus is revolutionising the pharmaceutical analytics space. Based in Eschborn, Hessen, Germany, this analytics company uses cutting-edge technology such as Artificial Intelligence (AI), Blockchain and advanced analytics to provide real-time insights to the life science industry. Founded in 2015, the organization aims to empower companies to move towards continuous decision-making by furnishing them with critical insights derived from both structured and unstructured data.

One of the primary goals at Innoplexus is removing the barriers to discovery in the life sciences and pharmaceutical sectors. By making relevant information readily available and accessible, it saves invaluable time and resources – which can often prove to be a roadblock in critical situations, and thus, fuels rapid growth.

What sets Innoplexus apart from other startups in the same domain, is its commitment to offer a seamless approach to data analytics. With its proprietary AI and Blockchain technology, it automates tasks that otherwise require arduous manual work such as collection, curation, aggregation, and analysis of data. This technology enables the company to process billions of data points from thousands of sources and deliver actionable insights to its clientele which includes leading Fortune 500 companies.

Moreover, its unique Data as a Service (DaaS) and Continuous Analytics as a Service (CaaS) solutions are significantly beneficial for industries like global banking, life sciences, and pharmaceutical companies since they consistently need to keep up with rapid changes in the business environment to remain productive and cost-effective.

Taking into consideration the advancements in the industry and the growing necessity for smart analytics, Innoplexus’s potential to transform the pharmaceutical analytics scene in Europe seems promising. As they continue to equip enterprises with real-time relevant insights, they are fast on track to redefine data-driven decision making and mark a new chapter in AI-driven pharmaceutical analytics.

Reach out to this revolutionary startup and and stay updated with their journey on their website, Twitter,
Facebook and
Linkedin.